| The glamour and gloom of glycogen synthase kinase-3 RS Jope, GVW Johnson Trends in biochemical sciences 29 (2), 95-102, 2004 | 1940 | 2004 |
| The multifaceted roles of glycogen synthase kinase 3β in cellular signaling CA Grimes, RS Jope Progress in neurobiology 65 (4), 391-426, 2001 | 1903 | 2001 |
| Glycogen synthase kinase-3 (GSK3): regulation, actions, and diseases E Beurel, SF Grieco, RS Jope Pharmacology & therapeutics 148, 114-131, 2015 | 1806 | 2015 |
| Toll-like receptor–mediated cytokine production is differentially regulated by glycogen synthase kinase 3 M Martin, K Rehani, RS Jope, SM Michalek Nature immunology 6 (8), 777-784, 2005 | 1348 | 2005 |
| Glycogen synthase kinase-3 (GSK3): inflammation, diseases, and therapeutics RS Jope, CJ Yuskaitis, E Beurel Neurochemical research 32, 577-595, 2007 | 998 | 2007 |
| The paradoxical pro-and anti-apoptotic actions of GSK3 in the intrinsic and extrinsic apoptosis signaling pathways E Beurel, RS Jope Progress in neurobiology 79 (4), 173-189, 2006 | 714 | 2006 |
| Lithium and GSK-3: one inhibitor, two inhibitory actions, multiple outcomes RS Jope Trends in pharmacological sciences 24 (9), 441-443, 2003 | 630 | 2003 |
| Regulation of Akt and glycogen synthase kinase-3β phosphorylation by sodium valproate and lithium P De Sarno, X Li, RS Jope Neuropharmacology 43 (7), 1158-1164, 2002 | 572 | 2002 |
| CREB DNA binding activity is inhibited by glycogen synthase kinase‐3β and facilitated by lithium CA Grimes, RS Jope Journal of neurochemistry 78 (6), 1219-1232, 2001 | 516 | 2001 |
| Anti-bipolar therapy: mechanism of action of lithium RS Jope Molecular psychiatry 4 (2), 117-128, 1999 | 498 | 1999 |
| Ectopically expressed CAG repeats cause intranuclear inclusions and a progressive late onset neurological phenotype in the mouse JM Ordway, S Tallaksen-Greene, CA Gutekunst, EM Bernstein, ... Cell 91 (6), 753-763, 1997 | 488 | 1997 |
| Glycogen synthase kinase-3 (GSK3) in psychiatric diseases and therapeutic interventions RS Jope, MS Roh Current drug targets 7 (11), 1421-1434, 2006 | 479 | 2006 |
| Innate and adaptive immune responses regulated by glycogen synthase kinase-3 (GSK3) E Beurel, SM Michalek, RS Jope Trends in immunology 31 (1), 24-31, 2010 | 470 | 2010 |
| High affinity choline transport and acetylCoA production in brain and their roles in the regulation of acetylcholine synthesis RS Jope Brain Research Reviews 1 (3), 313-344, 1979 | 435 | 1979 |
| The role of microtubule‐associated protein 2 (MAP‐2) in neuronal growth, plasticity, and degeneration GVW Johnson, RS Jope Journal of neuroscience research 33 (4), 505-512, 1992 | 428 | 1992 |
| Rapid accumulation of Akt in mitochondria following phosphatidylinositol 3‐kinase activation GN Bijur, RS Jope Journal of neurochemistry 87 (6), 1427-1435, 2003 | 420 | 2003 |
| Glycogen synthase kinase-3β facilitates staurosporine-and heat shock-induced apoptosis: protection by lithium GN Bijur, P De Sarno, RS Jope Journal of Biological Chemistry 275 (11), 7583-7590, 2000 | 406 | 2000 |
| In vivo regulation of glycogen synthase kinase-3β (GSK3β) by serotonergic activity in mouse brain X Li, W Zhu, MS Roh, AB Friedman, K Rosborough, RS Jope Neuropsychopharmacology 29 (8), 1426-1431, 2004 | 399 | 2004 |
| Direct, activating interaction between glycogen synthase kinase-3β and p53 after DNA damage P Watcharasit, GN Bijur, JW Zmijewski, L Song, A Zmijewska, X Chen, ... Proceedings of the National Academy of Sciences 99 (12), 7951-7955, 2002 | 362 | 2002 |
| Is glycogen synthase kinase-3 a central modulator in mood regulation? X Li, RS Jope Neuropsychopharmacology 35 (11), 2143-2154, 2010 | 344 | 2010 |
